Association of vitamin D receptor polymorphisms with cardiometabolic conditions in Pakistani population
Abstract
Abstract: Apart from bone related effects, vitamin D has roles in immune modulation, hypertension, diabetes and cardiovascular diseases. Metabolic functions of vitamin D are mediated after binding with vitamin D receptor (VDR). VDR polymorphisms affect its physiological functions. Several VDR single nucleotide polymorphisms (SNPs) were reported previously. However, VDR polymorphisms causing influence on cardiovascular and metabolic disorders have not been investigated in the Pakistani population so far. Therefore, the present study was conducted to evaluate the role of VDR polymorphisms (rs2228570 and rs7975232) in the pathobiology of cardiometabolic disorders. In total, 400 cardiometabolic patients and 226 healthy control human adults were enrolled from Faisalabad, Pakistan. Biochemical parameters (serum glucose, liver function test, renal function test and lipid profile) were analyzed by standard kit methods. Genetic analysis was done by ARMS-PCR assay. Data was analyzed in SPSS v20. Regression analysis revealed that GG and AG genotypes of rs2228570 A>G polymorphism significantly increased the risk of hypertension in cardiovascular patients by 5.29 and 5.94 times respectively (GG: OR=5.29, 95% CI=1.63–17.2, p=0.005; AG: OR=5.94, 95% CI=1.70–20.7, p=0.005). However, rs7975232 C>A polymorphism was not correlated with cardiometabolic conditions. In conclusion, GG and AG genotypes of VDR SNP rs2228570 significantly contribute to hypertension in cardiovascular disease patients.
References
1 . Vitamin D deficiency and cardiometabolic syndrome: Is the evidence solid? Arch Med Health Sci. 2017;5(2):229–36.
2 . Noncommunicable diseases country profiles 2018. 2018.
3 . Prevalence and contributing risk factors for hypertension in urban and rural areas of Pakistan; a study from second National Diabetes Survey of Pakistan (NDSP) 2016–2017. Clin Exp Hypertens. 2020;42(3):218–24.
4 Glycemic status and general characteristics among individuals with undiagnosed diabetes; findings from second National Diabetes Survey of Pakistan 2016, 2017 (NDSP 08). Diabetes Metab Syndr: Clin Res Rev. 2022;16(6):102535.
5 . Role of vitamin D in cardiometabolic diseases. J Diabetes Res. 2013;2013:10.
6 . Photobiology of vitamin D. 4th ed. Elsevier; 2018. 45–55.
7 . Vitamin D and its effects on cardiovascular diseases: a comprehensive review. Korean J Intern Med. 2016;31(6):1018–29.
8 . The modulatory action of vitamin D on the renin-angiotensin system and the determination of hepatic insulin resistance. Molecules (Basel, Switzerland). 2019;24(13):2479.
9 . Vitamin D deficiency and diabetes. Biochem J. 2017;474(8):1321–32.
10 . Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol. 2014;21(3):319–29.
11 Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–56.
12 Vitamin D deficiency, vitamin D receptor gene polymorphisms and cardiovascular risk factors in Caribbean patients with type 2 diabetes. Diabetes Metab. 2011;37(6):540–5.
13 . Risk conferred by FokI polymorphism of vitamin D receptor (VDR) gene for essential hypertension. Indian J Hum Genet. 2011;17(3):201–6.
14 . Association of ApaI polymorphism of vitamin D receptor gene with type 2 diabetes mellitus in Saudi population. J Exp Bio Agric Sci. 2017;5(2):271–6.
15 The associations between the polymorphisms of vitamin D receptor and coronary artery disease: a systematic review and meta-analysis. Medicine. 2016;95(21):1–9.
16 Association of vitamin D receptor gene polymorphisms with metabolic syndrome in rural areas of China. Biomed Environ Sci. 2019;32(4):304–8.
17 . 25-hydroxyvitamin D3 may function via genomic and non-genomic actions. Anat Physiol. 2017;7(4).
18 . Molecular mechanism of vitamin D in the cardiovascular system. J Investig Med. 2011;59(6):868–71.
19 . The renin–angiotensin–aldosterone system and calcium-regulatory hormones. J Hum Hypertens. 2015;29(9):515–21.
20 . Vitamin D receptor polymorphism rs2228570 is significantly associated with risk of dyslipidemia and serum LDL levels in Chinese Han population. Lipids Health Dis. 2018;17(193):1–8.
21 . Influence of polymorphism of vitamin D receptor (Fok I) on hypertension. Braz Arch Bio Technol. 2020;63:1–11.
22 . Association of FokI, TaqI, BsmI and ApaI polymorphisms with diabetic retinopathy: a pooled analysis of case-control studies. Afr Health Sci. 2018;18(4):891–9.
23 . Association of vitamin D receptor – a gene polymorphisms with coronary heart disease in Han Chinese. Int J Clin Exp Med. 2015;8(4):6224–9.
24 . vitamin D receptor gene polymorphisms and risk of coronary artery disease: findings from a meta-analysis with 5259 cases. Razi J Med. Sc. 2017;24(160):79–89.
25 . Interaction between vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D concentrations on metabolic and cardiovascular disease outcomes. Diabetes Metab. 2014;40(5):386–9.
26 . Association of rs2228570 polymorphism of vitamin D receptor gene with lumbar degenerative disc disease. Turk Neurosurg. 2019;29(2):159–63.
27 . Relationship between vitamin D receptor gene polymorphisms, cardiovascular risk factors and adiponectin in a healthy young population. Pharmacogenomics. 2016;17(15):1675–86.
28 Vitamin D receptor gene polymorphisms and plasma renin activity in essential hypertensive individuals. J Hum Hypertens. 2015;29(8):483–7.
29 . No effect of vitamin D supplementation on metabolic parameters but on lipids in patients with type 2 diabetes and chronic kidney disease. Int J Vitam Nutr Res. 2020;91(5–6):649–58.
30 . Study of vitamin D receptor gene polymorphism (FokI, TaqI and ApaI) among prostate cancer patients in North India. J Clin Diagn Res. 2017;11(6):Bc05–bc8.
31 . Vitamin D pathway related polymorphisms and vitamin D receptor expression in breast cancer. Int J Vitam Nutr Res. 2019;91(1–2):124–32.
32 . FokI vitamin D receptor gene polymorphism and serum 25-hydroxyvitamin D in patients with cardiovascular risk. Arch Med Sci Atheroscler Dis. 2019;4:e298–e303.
33 . Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis. BMC Nephrol. 2022;23(1):32.
34 . Vitamin D receptor gene polymorphism and vitamin D status in population of patients with cardiovascular disease – a preliminary study. Nutrients. 2021;13(9).
35 . Vitamin D receptor gene polymorphisms (TaqI and ApaI) in relation to 25-hydroxyvitamin D levels and coronary artery disease incidence. J Recept Signal Transduct Res. 2015;35(5):391–5.
36 . Association between vitamin D receptor (VDR) gene polymorphisms and type-2 diabetes mellitus in population of Pakistan. J Clin Med Genomics. 2018;6(2).
37 . Relationship of Apal VDR gene polymorphism to type 2 diabetes mellitus in Pakistani population. Pak J Med Health Sci. 2020;14(01):276–8.
